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Abstract
APSA PHYTAFEED® 20,000 GR/L is a preparation of 6-phytase which is presented in solid and liquid
forms. This additive is intended to be used as a zootechnical additive in chickens for fattening or reared
for laying/breeding and minor poultry species for fattening or reared for laying/breeding. The 6-
phytase present in the additive is produced by a genetically modified strain of Komagataella phaffii.
The production strain and its recombinant DNA were not detected in intermediate products used to
produce the additive. The final products do not trigger a safety concern with regard to the genetic
modification. Based on the results obtained in a tolerance study in chickens for fattening and the data
from a subchronic oral toxicity study the Panel on Additives and Products or Substances used in Animal
Feed (FEEDAP) concluded that the additive is safe for chickens for fattening. This conclusion was
extended to chickens reared for laying/breeding and extrapolated to all minor poultry species for
fattening or reared for laying/breeding. The FEEDAP Panel concluded that the use of APSA
PHYTAFEED® 20,000 GR/L as a feed additive gives rise to no concern for consumers. The additive, in
either form, is not toxic by inhalation or irritant for skin or eyes and it is not a dermal sensitizer, but it
is considered a potential respiratory sensitizer. The use of the product as a feed additive is of no
concern for the environment. The FEEDAP Panel evaluated three efficacy trials in which the retention of
the phosphorus was studied. The data showed that the additive has the potential to improve the
retention of phosphorus in the diets in chickens for fattening at 250 U/kg feed. This conclusion was
extended to chickens reared for laying/breeding and extrapolated to all minor poultry species for
fattening or reared for laying/breeding.
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Summary
Following a request from the European Commission, the European Food Safety Authority (EFSA)
was asked to deliver a scientific opinion on the safety and efficacy of APSA PHYTAFEED® 20,000 GR/L
(6-phytase). This additive is a preparation of 6-phytase and is presented in solid and liquid forms, and
it is intended to be used as a zootechnical additive (digestibility enhancer) in chickens for fattening or
reared for laying/breeding and minor poultry species for fattening or reared for laying/breeding.
The phytase present in the additive is produced by a genetically modified strain of Komagataella phaffii.
The production strain and its recombinant DNA was not detected in the intermediate products used to
formulate the additive. The final products do not trigger a safety concern with regard to the genetic
modification.
The solid and the liquid formulations are considered equivalent in terms of safety and efficacy for
the target species.
The recipient strain belongs to a species which is considered to qualify for the Qualified
Presumption of Safety (QPS) approach to safety assessment and the genetic modification to which it
was subject to does not give rise to concern. The results from toxicological studies including
genotoxicity and a subchronic oral toxicity study supported this conclusion. Therefore, the Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the use of APSA
PHYTAFEED® 20,000 GR/L as a feed additive gives rise to no concern for consumers.
Based on the results obtained in a tolerance study in chickens for fattening and the data from a
subchronic oral toxicity study the FEEDAP Panel concluded that the additive is safe for chickens for
fattening. This conclusion was extended to chickens reared for laying/breeding and extrapolated to all
minor poultry species for fattening or reared for laying/breeding.
The additive, in either form, is not toxic by inhalation or irritant for skin or eyes and it is not a
dermal sensitizer, but it is considered a potential respiratory sensitizer.
The use of the product as a feed additive is of no concern for the environment.
The FEEDAP Panel evaluated three efficacy trials in which the retention of phosphorus was studied.
The data showed that the additive has the potential to improve the retention of phosphorus in the
diets in chickens for fattening at 250 U/kg feed. This conclusion was extended to chickens reared for
laying/breeding and extrapolated to all minor poultry species for fattening or reared for laying/
breeding.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Andres Pintaluba S.A.2 for authorisation of the
product APSA PHYTAFEED® 20,000 GR/L (6-phytase), when used as a feed additive for chickens for
fattening, chickens reared for laying and minor poultry species (category: zootechnical additives;
functional group: digestibility enhancers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 18 July 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efficacy of the
product APSA PHYTAFEED® 20,000 GR/L (6-phytase), when used under the proposed conditions of
use (see Section 3.1.5).
1.2. Additional information
APSA PHYTAFEED® 20,000 GR/L is a feed additive that contains 6-phytase to be used in feed for
chickens for fattening, chickens reared for laying and minor poultry species as a zootechnical additive.
It has not been previously authorised in the European Union.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical dossier3
in support of the authorisation request for the use of APSA PHYTAFEED® 20,000 GR/L as a feed additive.
EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active substance in animal feed. The Executive Summary of the
EURL report can be found in Annex A.4
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of APSA
PHYTAFEED® 20,000 GR/L is in line with the principles laid down in Regulation (EC) No 429/20085 and
the relevant guidance documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a),
Technical guidance: Tolerance and efficacy studies in target animals (EFSA FEEDAP Panel, 2011),
Technical Guidance for assessing the safety of feed additives for the environment (EFSA, 2008a),
Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b),
Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel,
2012c), Technical Guidance: Extrapolation of data from major species to minor species regarding the
assessment of additives for use in animal nutrition (EFSA, 2008b), Guidance on the assessment of
bacterial susceptibility to antimicrobials of human and veterinary importance (EFSA FEEDAP
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Andres Pintaluba S.A. Pol. Ind. Agro Reus, c/. Prudenci Bertrana, 5, Reus 43206, Spain.
3 FEED dossier reference: FAD-2018-0031.
4 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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Panel 2012d), Guidance on the assessment of the safety of feed additives for the target species (EFSA
FEEDAP Panel, 2017) and Guidance on the risk assessment of genetically modified microorganisms and
their products intended for food and feed use (EFSA GMO Panel, 2011).
3. Assessment
The additive APSA PHYTAFEED® 20,000 GR/L, available in solid and liquid forms, contains 6-phytase
(EC 3.1.3.26; phytase) and it is intended to be used in feed for chickens for fattening, chickens reared
for laying and minor poultry species as a zootechnical additive (functional group: digestibility enhancers).
3.1. Characterisation
3.1.1. Characterisation of the active substance
The phytase present in the additive is produced by a genetically modified strain of the yeast
Komagataella phaffii that has been deposited in the China General microbiological Culture Collection
Centre (CGMCC) with the deposit number 12056.6
3.1.1.1. Information relating to the genetic modification
Characteristics of the recipient strain
3.1.1.2. Characteristics of the donor organism
3.1.1.3. Description of the genetic modification process
3.1.2. Manufacturing process
The enzyme is produced by fermentation with the production strain. The product obtained after
fermentation is filtrated and concentrated
6 Technical dossier/Section II/Annex II.2.1.2.Conf.
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3.1.3. Characterisation of the additive
The two formulations of the additive ensure a guaranteed minimum phytase activity of 20,000 U12/g
or mL of product.
The solid formulation, APSA PHYTAFEED® 20,000 GR,
. The batch-to-
batch variation of this formulation was studied in five batches and the mean value was 23,370 U/g
product, ranging from 21,600 to 24,700 U/g (with a coefficient of variation (CV) of 5.6%).13 The mean
particle size measured in three batches by laser diffraction was 227–243 lm, with no particles below 10
lm and less than 1% of particles below 50 lm.14 The dusting potential measured in three batches by the
Stauber–Heubach method was ≤ 30 mg/m3.15 The bulk density of the product is of 620 kg/m3.16
The liquid formulation, APSA PHYTAFEED® 20,000 L,
.
The batch-to-batch variation of this formulation was studied in five batches and the mean value was
23,188 U/ml, ranging from 21,800 to 24,600 U/ml (CV of 4.3%).13 This form of the additive has a
viscosity similar to 7 mPas at 20°C and a surface tension of 44 dyn/cm2.17
The two formulations were analysed for chemical and microbiological contamination (at least three
batches in each analysis).18 The analysis of the chemical contamination included arsenic
, cadmium , lead , mercury ,
fluorine , aflatoxin B1
deoxynivalenol , zearalenone fumonisin B1 fumonisin B2
ochratoxin A toxin T-2 and toxin HT2 methanol
and the sum of dioxins and dioxin-like PCBs
. Microbial analysis included total coliform bacteria
, E. coli and Salmonella spp. . No antimicrobial activity was
detected in three batches of the enzyme product
Therefore, the production strain and its DNA were not detected
in the intermediate products . These results apply to the final
product .
12 Unit, one unit is defined as the amount of enzyme that releases 1 lmol of inorganic phosphate from phytate per minute at pH
5.5 and 37°C.
13 Technical dossier/Section II/Annex II.1.3.3.
14 Technical dossier/Section II/Annex II.1.5.1.
15 Technical dossier/Section II/Annex II.1.5.2.
16 Technical dossier/Section II/Annex II.1.5.3.
17 Technical dossier/Section II/Annex II.1.5.4.
18 Technical dossier/Section II/Annex II.1.4.1.3, II.1.4.1.4, II.1.4.1.5.1 and II.1.4.1.5.2 and supplementary information February
2019.
APSA PHYTAFEED® 20,000 GR/L for chickens
www.efsa.europa.eu/efsajournal 7 EFSA Journal 2019;17(5):5692
3.1.4. Stability and homogeneity
The shelf-life of the additive is claimed to be 12 months for the solid formulation and 6 for the
liquid when stored at 20–25°C in closed packages. The shelf-life of the two formulations was studied in
three batches of either formulation stored in the closed containers at different temperatures and time
points.21 The enzyme activity in the solid formulation was 85% of the initial activity (25,500 U/g) when
stored at 25°C for 12 months and 40% of the initial activity when stored at 40°C for 6 months. The
enzyme activity in the liquid formulation was 95% of the initial activity (23,750 U/g) when stored at
5°C for 12 months (86% after 24 months under the same conditions) and 85% of the initial when
stored at 20°C for 6 months.
The stability of the phytase in a vitamin and mineral premixture (without choline chloride) was
studied in three batches of the solid formulation added to provide 125,000 U/kg premixture.22 Samples
were stored for 6 months at 25°C (container not specified). The enzyme activity after 6 months was
84% of the initial enzyme activity.
The stability of the phytase in feed was evaluated for the two formulations (one batch each) when
added to a complete feed for chickens for fattening.23 The two formulations of the additive were
added to a mash feed to provide 1,000 U/kg feed, the mash feed supplemented with the solid
formulation was also granulated in order to study the effect of the temperature. Recovery values after
granulation showed no modifications of the initial enzyme activity (recovery of 100%). Samples of the
mash and granulated were stored for 3 months at 25°C (containers not specified). After 3 months of
storage, recovery values showed no modifications of the initial enzyme activity.
The capacity of the phytase to homogeneously distribute was studied in 10 subsamples of the
premixture and feeds used in the stability studies. Samples analysed for the premixture showed a CV
of 9.6%. Samples of the mash feeds showed a CV of 8% for the solid formulation or of 6% for the
liquid formulation and the samples of the pelleted feed showed a CV of 6%.
3.1.5. Conditions of use
The additive is intended to be used in feed for chickens for fattening, chickens reared for laying
and minor poultry species for fattening purposes or up to the point of lay at a minimum enzyme
activity of 250 U/kg feed.
3.2. Safety
3.2.1. Safety of the genetic modification
The recipient strain from which the production organism was derived belongs to K. phaffii, which is
considered by EFSA to be suitable for the QPS approach to safety assessment when used for enzyme
production (EFSA BIOHAZ Panel, 2017).
The production
strain was identified as K. phaffii and the traits introduced raise no safety concerns. Therefore, the
additive does not pose any safety concern with regard to the genetic modification of the production
strain.
3.2.2. Toxicological studies
Toxicological studies are not required for fermentation products produced by a genetically modified
microorganism for which the recipient strain is considered by EFSA to qualify for the QPS approach to
safety assessment and for which the genetic modification raises no concerns. However, the applicant
submitted the below studies to support the safety of the additive.
Bacterial reverse mutation test
The liquid formulation of the additive was tested for the induction of reverse mutations in
Salmonella Typhimurium tester strains TA1535, TA1537 TA98, TA100 and TA102.24 The experimental
21 Technical dossier/Section II/Annex II.4.1.1.1 and II.4.1.1.2.
22 Technical dossier/Section II/Annex II.4.1.2.
23 Technical dossier/Section II/Annex II.4.1.3.1 and II.4.1.3.2.
24 Technical dossier/Section III/Annex III.2.2.2.1.
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protocol was in line with Organisation for Economic Co-operation and Development (OECD) guideline
471. The test item was dissolved in distilled water and tested both in the presence and absence of the
metabolic activation system at five different concentration levels up to 100 lL/plate25 in two
independent studies. In the second test, the pre-incubation method was used in the presence of
metabolic activation system.
No significant toxicity was observed but significantly increased numbers of revertant colonies were
observed in the positive controls. Statistically significant increases in the number of revertant colonies
were reported in strain TA1535 and TA102, in the absence of metabolic activation. The Panel noted
that the fold increase in revertant colony numbers was always below 2, the values were within the
historical vehicle control ranges and most of the results were not reproducible; on this basis, the
observed increases were considered not biologically relevant. It was concluded that the test item did
not induce gene mutations in bacteria under the test conditions employed in this study.
In vitro mammalian cell micronucleus test
The liquid formulation of the additive was evaluated in an in vitro micronucleus assay in human
peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy. The
experimental protocol was in line with OECD guideline 487.26 The maximum tested concentrations was
established in a preliminary experiment showing the induction of osmolarity changes (> 50 mOsmol
compared to the culture medium) at concentrations from 2.5% test item and above. Cells were
stimulated for 44–48 h with phytohaemaglutinin and then treated for 4 h (followed by a 24-h recovery
period) with concentrations ranging from 0.2 to 12.5 lL/mL dissolved in distilled water both in the
absence and in the presence of S9-mix. In a parallel assay, cells were treated for 28 h with the same
doses of the test item in the absence of S9-mix with no recovery period. The positive controls induced
statistically significant increases in the frequency of micronuclei, demonstrating the sensitivity of the
test system and the efficacy of the S9-mix. No significant cytotoxicity was observed. No statistically
significant increase in the frequency of micronuclei was observed at any dose and sampling time. It
was concluded that the test item did not induce micronuclei in cultured human peripheral blood
lymphocytes under the experimental conditions employed in this study.
Subchronic oral toxicity study
Sprague–Dawley CRl:OFA rats (10/sex per group) received the fermentation product by oral gavage
at 0 (control – water), 29,807, 59,614 or 119,228 U/kg body weight (bw) per day for 90 consecutive days
(up to 2 mL/kg bw per day). The study was conducted in compliance with OECD guideline 408 (1998).
In total, four rats died. One female in the highest dose died right after the first dosing (and was
replaced by a spare one). Two males (one from 29,807 and another one from 119,228 U/kg bw per
day groups) and one female (control group) died due to gavage practice.
Some clinical signs were noted on the males receiving the test item but these were isolated and not
treatment related. No differences were found on the food intake or in the body weight of the animals.
No abnormalities were identified in the ophthalmological examinations conducted. No changes in the
urinalyses, blood chemistry parameter or in the haematological and coagulation parameters were
found with the exception of a slightly lower activated partial thromboplastin time in females in the
29,807 U/kg bw group. No differences were found on the organ’s weight and the macroscopic
examination revealed similar incidence of isolated changes in the control and the dose groups. The
histopathological lesions noted were deemed to be incidental and not treatment related.
On the basis of the study, the Panel identified the no observed adverse effect level (NOAEL) of
119,228 U/kg bw per day (the highest dose tested).
3.2.3. Safety for the target species
In order to support the safety of the additive for the target species, the applicant submitted a
tolerance study and made reference to the results obtained in the subchronic oral toxicity study
presented in Section 3.2.2.
A total of 192 one-day-old male chickens for fattening (Ross 308) were distributed in 48 cages of 4
birds.27 Six dietary treatments were allocated to the pens, representing eight replicates per treatment.
Two basal diets (starter and grower) based on maize and soya bean meal (total phosphorus 4.0 and
25 Dose established in a preliminary toxicity assay.
26 Technical dossier/Section III/Annex III.2.2.2.2.
27 Technical dossier/Section III/Annex III.1.1.1 and Supplementary information February 2019.
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3.9 g/kg, total calcium 7.2 and 6.2 g/kg, respectively) were either not supplemented (control) or
supplemented with APSA PHYTAFEED® 20,000 GR to provide 250 (19 recommended level), 500,
1,000 or 100,000 (4009 recommended level) U per kg feed (confirmed by analysis). A positive control
diet with higher content of phosphorus was also considered (total phosphorus 5.9 g/kg for starter and
grower diets and total calcium 7.1 and 6.1 g/kg for starter and grower diets, respectively). Diets were
offered in mash form for 35 days. Mortality and health status were checked every day and dead
animals were necropsied. Animals were weighed on days 0, 21 and 35 (cage basis), feed intake was
registered throughout the study per cage and feed to gain ratio was calculated. Blood samples were
obtained from 1 bird per cage on day 35 for haematology and blood biochemistry.28 An analysis of
variance (ANOVA) was done with the data and considering the treatment as a fixed effect and block
(situation of the cage) as a random effect. Group means were compared with the Tukey test. The
significance level was set at 0.05.
Mortality including culling was 4% and not treatment related. The results on the feed intake, body
weight and feed to gain ratio are presented in Table 1. Birds in the control diet showed a statistically
significant lower feed intake and final body weight compared to the other groups. The body weight
gain in the control group was 30% lower compared to performance objectives for the breed. No
differences in the feed intake, final body weight and feed to gain ratio of the birds were found
between the groups fed the phytase and the positive control, with the exception of a lower feed intake
in the 250 U/kg feed compared to positive control. No statistical differences were observed in any of
the parameters measured in blood.
The low performance registered in the control group does not allow to use it as a control to identify
any impairment of the performance in animals receiving the phytase. However, the data from the
groups receiving the phytase did not show a negative dose-related trend with increasing levels of the
phytase in the performance; in fact, improvements on the performance were seen with increasing
levels of the phytase. Moreover, no significant differences in the performance of the birds that received
the phytase were evidenced compared to the positive control diet. Therefore, the data from this
tolerance trial would indicate that the birds could tolerate well the phytase at the recommended level.
A subchronic oral toxicity study was provided in support to the safety for the target species
(described in Section 3.2.2). The results of that study indicate a NOAEL of 119,228 U/kg bw in rats.
From this NOAEL, the applicant calculated the maximum safe level for chickens for fattening in feed
according to the guidance on the safety for the target species (EFSA FEEDAP Panel, 2017). The result
of the calculation was 13,281 U/kg feed, and this would support the results of the tolerance study and
indicate a wide margin of safety, approximately 50.
3.2.3.1. Conclusions on the safety for the target species
The FEEDAP Panel concludes that APSA PHYTAFEED® GR/L is safe for chickens for fattening at the
recommended level of 250 U/kg feed with a wide margin of safety. This conclusion is extended to
chickens reared for laying and considering the wide margin of safety, the conclusion can be extrapolated
to minor poultry species for fattening purposes or reared for laying/breeding purposes. The solid and the
liquid formulations are considered equivalent in terms of safety for the target species.
Table 1: Effect of APSA PHYTAFEED® 20,000 on the performance of chickens for fattening
Groups
(U/kg feed)
Daily feed intake
(g)
Final body weight
(g)
Feed to gain ratio
Mortality
(n)
0 65.1c 1,563c 1.50 3
250 75.0b 1,820b 1.48 1
500 80.6ab 1,913ab 1.51 1
1,000 81.5ab 1,974ab 1.48 1
100,000 83.4a 2,040a 1.47 0
Positive control 82.8a 1,970ab 1.51 2
a,b,cvalues in the same column not sharing the same superscript are significantly different (p < 0.05).
28 Total count for red blood cells, packed cell volume, haemoglobin, mean corpuscular volume, mean corpuscular haemoglobin,
mean corpuscular haemoglobin concentration, total and differential counts for leukocytes, total protein, albumin, uric acid,
alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase.
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3.2.4. Safety for the consumer
The enzyme is produced by a genetically modified strain of K. phaffii; this species is considered to
qualify for the QPS approach to safety assessment when used for enzyme production. The identity of
the strain was established, and the genetic modification of the production strain raises no concerns.
Therefore, the production strain is presumed safe for production purposes and no concerns would
raise for the consumer from the fermentation product obtained from this strain. The results obtained
in the genotoxicity studies and the subchronic oral toxicity support this conclusion.
3.2.5. Safety for the user
3.2.5.1. Effects on the respiratory system
No specific tests were submitted; however, based on the proteinaceous nature of the active
substance of the additive, it is considered as a potential respiratory sensitiser.
3.2.5.2. Effects on the skin and eyes
The skin and eye irritation potential of the liquid and the solid formulations of the additive were
tested in valid studies performed according to OECD guideline 404 and 405, which showed that they
are not irritants to skin or eyes.29
Both solid and liquid formulations were tested for skin sensitisation following the OECD guideline
406.30 The solid formulation tested at 100% concentration elicited at 24 h and 48 h, in two and one
animals (corresponding to 20% and 10% of animals tested, respectively) a slight erythema. The liquid
formulation tested at 100% concentration elicited in two animals (20% of animals tested) mild
sensitisation after 24 and 48 h. According to the classification, labelling and packaging of substances and
mixtures criteria (European Chemical Agency, 2017), the two formulations are classified as non-dermal
sensitizers.
3.2.5.3. Conclusions on safety for the user
The additive, in either form, is not a skin or eye irritant and it is not a dermal sensitizer. However,
owing to the proteinaceous nature of the active substance, it should be considered a potential
respiratory sensitizer.
3.2.6. Safety for the environment
The production strain and its DNA were not detected .
The additive does not raise safety concerns for the environment with regard to the genetic
modification of the production strain.
The active substance of the additive is a protein, and as such will be degraded/inactivated during
passage through the digestive tract of animals or in the environment. Therefore, no risks to the
environment are expected and no further environmental risk assessment is required.
3.3. Efficacy
Two balance trials and a performance trial, which included a balance, done in chickens for fattening
were submitted for the assessment.
The two short-term trials shared a similar design. In the first, 320 one-day-old male chickens for
fattening (Arbor Acres plus) were distributed in 40 cages in groups of 8 birds.31 In the second, 480
one-day-old male chickens for fattening (Cobb 500) were distributed in 24 pens in groups of 20
birds.32 Basal diets based on maize and soya bean meal were either not supplemented (control) or
supplemented with APSA PHYTAFEED® 20,000 GR to provide different levels of the phytase including
the recommended level in the two studies (Table 2, trials 1 and 2). The enzyme activities were
confirmed by analysis. In trial 1, a positive control diet with higher content of phosphorus was also
considered. Diets were offered in mash form for 21 or 28 days, respectively, and contained titanium
dioxide as an external marker. Mortality and health status were checked every day and dead animals
were necropsied. Animals were weighed on days 0 and 21 (cage basis) in trial 1 or on weekly basis in
29 Technical dossier/Section III/Annexes III.3.1.2.1 to III.3.1.2.4.
30 Technical dossier/Section III/Annexes III.3.1.2.5 and III.3.1.2.6.
31 Technical dossier/Section IV/Annex IV.2.1 and Supplementary information IV.2.1.
32 Technical dossier/Section IV/Annex IV.2.2.
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trial 2. Feed intake was measured throughout the study period. In trial 1, the balance study was
conducted on days 19–21 of life, with total collection of excreta for 4 days. In trial 2, on day 26 of life,
two birds per pen were selected based on average body weight of the pen and were individually caged
(16 birds per treatment) to perform the balance study, excreta samples were collected for three days
(days 26–28). At the end of the balance trials, one bird per cage in trial 1 or two birds per cage in trial
2 were killed and tibia bones were collected. Feed and excreta samples were analysed for titanium,
phosphorus, calcium, dry matter and ash to determine the utilisation and tibia content of ash (trial 1)
or ash and phosphorus (trial 2). An ANOVA was done with the data and group means were compared
with the Tukey test. The significance level was set at 0.05.
The long-term trial is the tolerance trial presented in Section 3.2.1. In that trial, the performance of
the birds was measured and a balance study was performed on days 19–21 of life of the chicks. The
diets contained titanium dioxide as an external marker and the total excreta was collected during the
study period. Feed and excreta samples were analysed for the marker, ash, dry matter, calcium and
phosphorus to determine the utilisation. Moreover, one bird per cage, randomly chosen on day 21, was
killed for tibia bones collection. The bones were analysed for ash content.
The results of the balance trials are presented in Table 2 and the performance parameters of trial 3
in Table 1 (see Section 3.2.2).
The birds that received the phytase showed significant improvements on the phosphorus retention
in the three balance trials submitted, the effects being seen from the addition of 250 U/kg feed. Also,
improvements on the tibia mineralisation were observed in the three trials, in two trials from 250 U/kg
feed and in one from 1,000 U/kg feed. These results would support the efficacy of the phytase in
improving the utilisation of phosphorus in chickens for fattening from the addition of 250 U/kg feed.
In the long-term trial, the performance of the birds was improved by the phytase compared to
control from the addition of 250 U/kg. The growth of the animals in the control group was rather slow,
probably due to the low level of phosphorus in the control diet. However, a positive control was
included in the study and the performance of the birds in this positive control group was not
significantly different to the phytase groups. This result would also support the efficacy of the additive
in improving the utilisation of phosphorus.
3.3.1. Conclusions on the efficacy
Based on improvements on the utilisation of phosphorus from three balance studies, the
Panel concludes that APSA PHYTAFEED® 20,000 GR/L has the potential to be efficacious as a
Table 2: Effect of APSA PHYTAFEED 20,000® on the phosphorus utilisation and tibia bone content1
Trial
Diets
Phosphorus
retention (%)
Bone content (%)
Phytase
(Units/kg feed)
Total P – Ca
(g/kg feed)2
Ash Phosphorus
1 0 5.7–9.0 46.5b 45.4a –
250 5.7–9.0 54.0c 51.2b –
500 5.7–9.0 55.2c 51.9b –
1,000 5.7–9.0 59.7c 52.9b –
2 0 6.7–10.0 37.9a 52.4b –
0 3.7–8.4 37.6a 23.9a 3.9a
250 3.7–8.4 47.8b 27.8b 4.9b
500 3.7–8.4 52.3c 30.5c 5.5c
3 0 4.0–7.2 31.0e 36.4b –
250 4.0–7.2 43.9c 37.5b –
500 4.0–7.2 47.9c 38.5b –
1,000 4.0–7.2 61.3b 44.1a –
100,000 4.0–7.2 68.6a 46.8a –
Positive control 5.9–7.1 36.3d 43.3a –
1Values are obtained from eight replicates per treatment in trials 1 and 3 and 16 in trial 2.
2Intended values for the diets administered during the balance trial.
a,b,c,d,eValues in the same column not sharing the same superscript are significantly different (p < 0.05).
APSA PHYTAFEED® 20,000 GR/L for chickens
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2019;17(5):5692
zootechnical additive in chickens for fattening at the recommended level of 250 U/kg feed. This
conclusion is extended to chickens reared for laying/breeding purposes. Considering that the mode of
action of the phytases is well known and it is reasonably assumed to be the same among poultry
species, the Panel extrapolates the conclusions on the efficacy to minor poultry species for growing or
reared for laying/breeding. The solid and the liquid formulations are considered equivalent in terms of
efficacy for the target species.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation33 and Good
Manufacturing Practice.
4. Conclusions
The production strain is considered safe for production purposes and the genetic modification raises
no concerns. Viable cells of the production strain and its DNA were not detected in the additive.
APSA PHYTAFEED® 20,000 GR/L is safe for chickens for fattening or reared for laying/breeding and
for minor poultry species for fattening or reared for laying/breeding at the recommended level of
250 U/kg feed.
The additive is safe for the consumers of food derived from animals fed with the additive.
The additive is not irritant for skin or eye and it is not a dermal sensitiser, but it is considered a
potential respiratory sensitiser.
The use of the product as a feed additive is of no concern for the environment.
APSA PHYTAFEED® 20,000 GR/L has the potential to improve the utilisation of phosphorus in the
diets in chickens for fattening or reared for laying/breeding and for minor poultry species for fattening
or reared for laying/breeding at 250 U/kg feed.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for APSA PHYTAFEED® 20,000 GR/L
In the current application, authorisation in is sought under article 4(1) of Regulation (EC) No 1831/2003
for APSA PHYTAFEED® under the category/functional group 4(a) “zootechnical additives”/“digestibility
enhancers”. Specifically, authorisation is sought for chickens for fattening, chickens reared for laying and
minor poultry species.
According to the Applicant, 6-phytase is the active substance of APSA PHYTAFEED® produced by
Komagataella pastoris appa T75 (CGMCC 12056). The Applicant expresses the phytase enzymatic
activity in units (U), where ‘one U is the amount of enzyme which releases one micromole of inorganic
phosphate from phytate per minute at pH 5.5 and 37°C’.
The product is intended to be marketed as a granulated and a liquid formulation having a guaranteed
minimum phytase activity of 20,000 U/g (APSA PHYTAFEED® 20000 GR) and of 20,000 U/mL (APSA
PHYTAFEED® 20000 L). APSA PHYTAFEED® is intended to be included into feedingstuffs directly and/or
through premixtures to obtain a minimum activity of 250 U/kg feedingstuffs.
For the determination of phytase in the feed additive, premixtures and feedingstuffs, the Applicant
applied a modified protocol of the EN ISO 30024 standard method. Upon request of the EURL the
Applicant applied (i) the ring-trial validated colorimetric EN ISO 30024 standard method for the
quantification of the phytase activity in feedingstuffs, (ii) the ring-trial validated colorimetric method
(VDLUFA 27.1.3) for the quantification of the phytase activity in premixtures and (iii) the ring-trial
validated colorimetric method (VDLUFA 27.1.4) for the quantification of the phytase activity in the feed
additives. Comparable results and method performance characteristics were obtained and demonstrate
the applicability of these methods to the determination of phytase activity in feed additive, premixtures
and feedingstuffs of the product under investigation.
Based on the performance characteristics provided the EURL recommends for official control the
colorimetric methods mentioned above for the quantification of phytase activity in the feed additive,
premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005, as last
amended by Regulation (EU) 2015/1761) is not considered necessary.
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